| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |